Interesting. So the core question seems to be: “How much value is produced by healthy blood donors making decisions to donate without incentives, compared to blood that’s “brought”″.
Bought blood has been subject of an interesting debate:
“Since increased blood shortages are to be expected anyway in the near future, all measures improving the supply of safe blood, including monetary compensation, should be objectively discussed without prejudice.”
“Paid blood donation still has its defenders, who cite economic doctrines denying the existence of altruism per se, the inability of most countries with exclusively voluntary donations to achieve self-sufficiency and the supposedly successful use of selected groups of paid donors.”
“Majority would consent to free blood donation only in case of emergency or as a family replacement...”
“Several countries are already self-sufficient in blood and blood products, based on a voluntary, unpaid donor system.”
“The European Association of the Plasma Products [...] believes that the most important aspect of self-sufficiency is a sufficient supply of safe and efficacious product; the question of paid or unpaid donations is of lower importance.”
Interesting. So the core question seems to be: “How much value is produced by healthy blood donors making decisions to donate without incentives, compared to blood that’s “brought”″.
Bought blood has been subject of an interesting debate:
“Since increased blood shortages are to be expected anyway in the near future, all measures improving the supply of safe blood, including monetary compensation, should be objectively discussed without prejudice.”
“Paid blood donation still has its defenders, who cite economic doctrines denying the existence of altruism per se, the inability of most countries with exclusively voluntary donations to achieve self-sufficiency and the supposedly successful use of selected groups of paid donors.”
“Majority would consent to free blood donation only in case of emergency or as a family replacement...”
“Several countries are already self-sufficient in blood and blood products, based on a voluntary, unpaid donor system.”
“The European Association of the Plasma Products [...] believes that the most important aspect of self-sufficiency is a sufficient supply of safe and efficacious product; the question of paid or unpaid donations is of lower importance.”